Results 21 to 30 of about 79,961 (249)
Pre-Ebola virus disease laboratory system and related challenges in Liberia
Prior to the Ebola virus disease outbreak in Liberia, the laboratory system was duplicativefragmented and minimally coordinated. The National Reference Laboratory was conceptualisedto address the existing challenges by promoting the implementation of ...
Stephen B. Kennedy +7 more
doaj +1 more source
Background: Ebola virus emerged in West Africa in December 2013. The ease of mobility, porous borders, and lack of public health infrastructure led to the largest Ebola virus disease (EVD) outbreak to date.
Lance D. Presser +34 more
doaj +1 more source
Repurposed Medicines for Viruses With Epidemic or Pandemic Potential: A Horizon Scan. [PDF]
ABSTRACT Viruses such as Ebola, Marburg, influenza, mpox, MERS‐CoV, SARS‐CoV, and SARS‐CoV‐2 may be considered pathogens of epidemic or pandemic concern. Developing novel antiviral medicines can be time‐consuming and resource intensive. Repurposing existing medicines with known or potential antiviral activity offers a faster, cost‐effective strategy to
Akinbolade S +5 more
europepmc +2 more sources
Promising vaccines and results from recent clinical trials of therapeutic antibodies against Ebola virus offer hope for an end to this devastating disease. We asked three investigators in the field to share their views on the remaining challenges and important future research directions as we work toward controlling Ebola virus infection.
openaire +2 more sources
Domestic sea transport is critical to all aspects of life in the Pacific, providing access to markets and health and education services, as well as enabling cultural and social connectivity. Current sea transport services are entirely dependent upon use
Alison Patricia Newell, Amelia eBola
doaj +1 more source
Roundtable discussion on the Third Global Symposium on Health Systems Research: why prioritise talk over aid in the midst of the Ebola crisis? [PDF]
Health systems experts from around the world discuss why they were meeting at the Third Global Symposium on Health Systems Research while people were dying of Ebola in West ...
Safreed-Harmon, Kelly +30 more
core +1 more source
We welcome the results from the Ebola ça Suffit (“Ebola that is enough”) trial, emphasising the potential importance of a vaccine in controlling Ebola virus disease. However, parallel development in children and adolescents is scarce. More than 3000 confirmed cases of Ebola virus disease in children younger than 14 years have been reported, including ...
Sarah, Tschudin-Sutter +4 more
openaire +4 more sources
Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [PDF]
Emerging viral diseases pose a threat to the global population as intervention strategies are mainly limited to basic containment due to the lack of efficacious and approved vaccines and antiviral drugs.
Temperton, Nigel J. +24 more
core +1 more source
On the coloniality of global public health
The continued inordinate demise from communicable pathogens in the global South is not the result of an intractable problem thwarting our best efforts to prevent and cure disease; we have the means.
Eugene T. Richardson
doaj +1 more source
Impact of disease information (Ebola and COVID-19) on the pharmaceutical sector in Russia and USA
Objective: identification of the relationship between the news coverage of global diseases and the dynamics of the return on shares of the pharmaceutical sector for Russia and the United States.Material and methods.
E. A. Fedorova +3 more
doaj +1 more source

